Boundless Bio, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Boundless Bio, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2023 to Q3 2024.
  • Boundless Bio, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$185M.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$185M Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$169M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$152M Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$136M Dec 31, 2023 10-Q 2024-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.